Threshold Pharmaceuticals Company Profile (NASDAQ:THLD)

About Threshold Pharmaceuticals

Threshold Pharmaceuticals logoThreshold Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. It is developing two therapeutic product candidates based on hypoxia-activated prodrug technology: evofosfamide and tarloxotinib. Evofosfamide is designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not in healthy tissues. Tarloxotinib is under investigation in two Phase II proof-of-concept trials: one for the treatment of patients with mutant EGFR-positive, T790M-negative advanced NSCLC progressing on an EGFR TKI, and the other for patients with recurrent or metastatic squamous cell carcinomas of the head and neck. [18F]-HX4 is an investigational Positron Emission Tomography imaging agent for hypoxia to identify and quantify the degree of hypoxia in tumors in vivo.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: THLD
  • CUSIP: 88580720
Key Metrics:
  • Previous Close: $0.60
  • 50 Day Moving Average: $0.5532
  • 200 Day Moving Average: $0.6386
  • 52-Week Range: $71,560,000.00 - $0.22
  • Trailing P/E Ratio: 1.0037
  • Foreward P/E Ratio: -2.08
  • P/E Growth: 0.0000
  • Market Cap: $43.24M
  • Outstanding Shares: 71,560,000
  • Beta: 4.85
Profitability:
  • Return on Equity: 101.72%
  • Return on Assets: 79.46%
Debt:
  • Current Ratio: 7.96%
  • Quick Ratio: 7.96%
Additional Links:
Companies Related to Threshold Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Threshold Pharmaceuticals (NASDAQ:THLD) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $0.52 (13.94% downside)

Analysts' Ratings History for Threshold Pharmaceuticals (NASDAQ:THLD)
Show:
DateFirmActionRatingPrice TargetDetails
10/3/2016William BlairReiterated RatingOutperformView Rating Details
9/30/2016S&P Equity ResearchLower Price Target$0.67 -> $0.52View Rating Details
12/7/2015Piper Jaffray CompaniesDowngradeOverweight -> NeutralView Rating Details
12/7/2015Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details
12/7/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details
10/5/2015Cantor FitzgeraldReiterated RatingBuy$14.00View Rating Details
9/15/2015Royal Bank of CanadaReiterated RatingBuyView Rating Details
6/4/2015MLV & Co.Set Price TargetBuy$14.50View Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for Threshold Pharmaceuticals (NASDAQ:THLD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/8/2017        
11/7/2016Q3($0.09)($0.08)ViewN/AView Earnings Details
8/1/2016Q216($0.10)($0.10)ViewN/AView Earnings Details
5/5/2016Q1($0.02)($0.11)ViewN/AView Earnings Details
3/10/2016Q4($0.11)$0.86ViewN/AView Earnings Details
11/2/2015Q315($0.14)($0.09)$3.69 million$3.70 millionViewN/AView Earnings Details
7/30/2015Q2($0.14)($0.12)ViewN/AView Earnings Details
4/30/2015($0.14)($0.17)ViewN/AView Earnings Details
3/3/2015Q414($0.13)($0.12)$3.70 millionViewN/AView Earnings Details
11/3/2014Q314($0.12)($0.15)$3.82 million$3.70 millionViewN/AView Earnings Details
8/1/2014($0.13)($0.12)ViewN/AView Earnings Details
5/1/2014($0.10)($0.12)ViewN/AView Earnings Details
3/6/2014Q413($0.10)($0.13)$3.58 million$3.20 millionViewN/AView Earnings Details
11/4/2013Q313($0.14)$0.02$3.15 million$3.20 millionViewN/AView Earnings Details
5/2/2013Q1 2013($0.09)($0.16)$2.80 million$2.90 millionViewN/AView Earnings Details
11/2/2012Q312($0.06)($0.06)$2.29 million$1.80 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Threshold Pharmaceuticals (NASDAQ:THLD)
Current Year EPS Consensus Estimate: $-0.3600 EPS
Next Year EPS Consensus Estimate: $-0.2900 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.15)($0.15)($0.15)
Q2 20161($0.12)($0.12)($0.12)
Q3 20161($0.09)($0.09)($0.09)
Q4 20161($0.08)($0.08)($0.08)
Q1 20171($0.06)($0.06)($0.06)
Q2 20171($0.06)($0.06)($0.06)
Q3 20171($0.06)($0.06)($0.06)
Q4 20171($0.06)($0.06)($0.06)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Threshold Pharmaceuticals (NASDAQ:THLD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Threshold Pharmaceuticals (NASDAQ:THLD)
Insider Ownership Percentage: 12.97%
Institutional Ownership Percentage: 28.71%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/18/2015Wilfred E JaegerDirectorBuy25,000$3.75$93,750.00View SEC Filing  
10/13/2014Nipun DavarVPBuy3,000$2.99$8,970.00View SEC Filing  
10/1/2014Hill Ventures SutterMajor ShareholderSell226,657$3.77$854,496.89View SEC Filing  
10/1/2014Jeffrey W BirdDirectorSell238,520$3.77$899,220.40View SEC Filing  
6/20/2014David L AndersonMajor ShareholderSell13,988$4.01$56,091.88View SEC Filing  
1/16/2014Wilfred JaegerDirectorSell96,356$4.86$468,290.16View SEC Filing  
1/15/2014Wilfred JaegerDirectorSell424,956$4.87$2,069,535.72View SEC Filing  
1/10/2014Wilfred JaegerDirectorSell723,900$4.88$3,532,632.00View SEC Filing  
7/15/2013Wilfred E JaegerDirectorSell322,000$5.53$1,780,660.00View SEC Filing  
7/11/2013Wilfred E JaegerDirectorSell178,000$5.51$980,780.00View SEC Filing  
7/5/2013Wilfred E JaegerDirectorSell219,667$5.53$1,214,758.51View SEC Filing  
6/19/2013Wilfred E JaegerDirectorSell2,000$5.50$11,000.00View SEC Filing  
6/18/2013Wilfred E JaegerDirectorSell124,733$5.51$687,278.83View SEC Filing  
6/10/2013Wilfred E JaegerDirectorSell153,600$5.48$841,728.00View SEC Filing  
5/31/2013David L AndersonMajor ShareholderSell266,542$5.72$1,524,620.24View SEC Filing  
5/31/2013Jeffrey W BirdDirectorSell273,181$5.72$1,562,595.32View SEC Filing  
5/22/2013Tillman PearceInsiderSell20,000$5.63$112,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Threshold Pharmaceuticals (NASDAQ:THLD)
DateHeadline
News IconAnalysts Peer Into Their Crystal Balls For Threshold Pharmaceuticals, Inc. (NASDAQ:THLD): Where Is It headed? - Winfield Review (NASDAQ:THLD)
winfieldreview.com - February 22 at 8:50 PM
News IconAnalyst Consensus Estimates & Projections are in For Shares of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Aiken Advocate (NASDAQ:THLD)
aikenadvocate.com - February 22 at 8:50 PM
istreetwire.com logoStocks Highlights: Threshold Pharmaceuticals, Inc. (THLD), Kohl's Corporation (KSS), KB Home (KBH) - iStreetWire (NASDAQ:THLD)
istreetwire.com - February 17 at 7:04 PM
News IconThreshold Pharmaceuticals, Inc. (THLD): An Examination Of The Chart For Today's Session - NY Stock News (NASDAQ:THLD)
nystocknews.com - February 17 at 7:04 PM
News IconStock Check: Reviewing the Numbers for Threshold Pharmaceuticals Inc. (THLD) - Rives Journal (NASDAQ:THLD)
rivesjournal.com - February 13 at 8:43 PM
News IconIs the Needle Ready to Move on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Prospect Journal (NASDAQ:THLD)
prospectjournal.com - February 1 at 6:53 AM
News IconCalibrating the Trade: Watching Technicals on Shares of Threshold Pharmaceuticals Inc. (THLD) - Sherwood Daily (NASDAQ:THLD)
sherwooddaily.com - January 31 at 3:53 AM
News IconIndicator Level Summary for Threshold Pharmaceuticals Inc. (THLD) - Sherwood Daily (NASDAQ:THLD)
sherwooddaily.com - January 28 at 6:56 AM
News IconThreshold Pharmaceuticals, Inc. (NASDAQ:THLD) Daily Sentiment Score At 0 - Stock Observer (NASDAQ:THLD)
www.thestockobserver.com - January 28 at 6:56 AM
News IconThreshold Pharmaceuticals, Inc. (THLD) Analyst Coverage - NewsDen (NASDAQ:THLD)
newsden.net - January 27 at 6:13 AM
News IconTrading Spotlight: Zooming in on Shares of Threshold Pharmaceuticals Inc. (THLD) - Sherwood Daily (NASDAQ:THLD)
sherwooddaily.com - January 27 at 6:13 AM
News IconEarnings in Full Force, Analysts Take Aim at Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Wall Street Beacon (NASDAQ:THLD)
wsbeacon.com - January 27 at 6:13 AM
News IconWatching the Charts on Threshold Pharmaceuticals Inc. (THLD) - Sherwood Daily (NASDAQ:THLD)
sherwooddaily.com - January 26 at 6:18 AM
News IconEarnings Take Center Stage; Analysts Weighing in on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Aiken Advocate (NASDAQ:THLD)
aikenadvocate.com - January 26 at 6:18 AM
News IconQuarterly EPS Of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) Set At $-0.06 - Stock Observer (NASDAQ:THLD)
www.thestockobserver.com - January 26 at 6:18 AM
News IconTrading Sheet: Tracking Technicals for Threshold Pharmaceuticals Inc. (THLD) - Sherwood Daily (NASDAQ:THLD)
sherwooddaily.com - January 25 at 6:38 AM
investornewswire.com logoThreshold Pharmaceuticals, Inc. (NASDAQ:THLD) Records An Impact Score Of 66 - Investor Newswire (NASDAQ:THLD)
www.investornewswire.com - January 23 at 8:05 AM
News IconWall Street Holds Inauguration Gains, How Did This Stock Fare: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Wall Street Beacon (NASDAQ:THLD)
wsbeacon.com - January 23 at 8:05 AM
News IconTrading Corner: Eye on Technical Levels for Threshold Pharmaceuticals Inc. (THLD) - Sherwood Daily (NASDAQ:THLD)
sherwooddaily.com - January 21 at 3:20 AM
News IconThreshold Pharmaceuticals, Inc. (NASDAQ:THLD) Daily Sentiment Score At 0.172 - Stock Observer (NASDAQ:THLD)
www.thestockobserver.com - January 21 at 3:20 AM
News IconIs This Stock Ready to Rumble: Threshold Pharmaceuticals, Inc ... - Prospect Journal (NASDAQ:THLD)
prospectjournal.com - January 21 at 3:20 AM
News IconTaking a Fresh Look at Threshold Pharmaceuticals, Inc. (THLD) - StockNewsJournal (NASDAQ:THLD)
stocknewsjournal.com - January 18 at 8:57 AM
News IconIs There Any Upside to This Stock Under $5: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Prospect Journal (NASDAQ:THLD)
prospectjournal.com - January 18 at 8:57 AM
News IconWill The Needle Move For Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:THLD)
wsbeacon.com - January 14 at 8:56 PM
News IconThreshold Pharmaceuticals, Inc. (NASDAQ:THLD) Daily Sentiment Score At 0.373 - Stock Observer (NASDAQ:THLD)
www.thestockobserver.com - January 14 at 8:56 PM
News IconMarkets End Mostly Higher, How Did This Stock Fare: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Wall Street Beacon (NASDAQ:THLD)
wsbeacon.com - January 14 at 8:56 PM
News IconPrimed for Breakout or Bust? A look at Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Prospect Journal (NASDAQ:THLD)
prospectjournal.com - January 11 at 6:14 AM
News IconPlacing This Stock in the Hotbed: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Prospect Journal (NASDAQ:THLD)
prospectjournal.com - January 11 at 6:14 AM
News IconCurious Investors Should Take a Look at This Small Cap Stock: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Prospect Journal (NASDAQ:THLD)
prospectjournal.com - January 5 at 7:03 AM
News IconCheap Stock, But is it a Bargain: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Prospect Journal (NASDAQ:THLD)
prospectjournal.com - January 4 at 6:31 AM
News IconVC Score in Review for Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Wall Street Beacon (NASDAQ:THLD)
wsbeacon.com - January 4 at 6:31 AM
News IconBearish Target Of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) At $1 - Stock Observer (NASDAQ:THLD)
www.thestockobserver.com - January 2 at 7:56 PM
News IconDaily Sentiment Score Of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) At -0.203 - Stock Observer (NASDAQ:THLD)
www.thestockobserver.com - December 31 at 6:04 AM
News IconAre Discerning Investors Interested in These Shares: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Prospect Journal (NASDAQ:THLD)
prospectjournal.com - December 29 at 8:09 PM
News IconThreshold Pharmaceuticals, Inc. (NASDAQ:THLD) Bearish Target At $1 - Stock Observer (NASDAQ:THLD)
www.thestockobserver.com - December 26 at 8:47 AM
News IconThreshold Pharmaceuticals, Inc. (NASDAQ:THLD) Daily Sentiment ... - Stock Observer (NASDAQ:THLD)
www.thestockobserver.com - December 25 at 8:39 AM
News IconAre There Any Catalysts to Propel Shares of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Prospect Journal (NASDAQ:THLD)
prospectjournal.com - December 22 at 4:33 AM
News IconCompany Stock Watch: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Liberty News (NASDAQ:THLD)
libertynewsrecord.com - December 22 at 4:33 AM
News IconThreshold Pharmaceuticals and National Cancer Institute to Collaborate on Drug Candidate TH-3424 - EconoTimes (NASDAQ:THLD)
www.econotimes.com - December 20 at 8:38 PM
News IconBoom or Bust? Is there any value in Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Prospect Journal (NASDAQ:THLD)
prospectjournal.com - December 20 at 8:38 PM
News IconStock Levels in View for Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - OIB News (NASDAQ:THLD)
oibnews.com - December 20 at 8:38 PM
4-traders.com logoThreshold Pharmaceuticals : and National Cancer Institute to Collaborate on Drug Candidate TH-3424 (NASDAQ:THLD)
www.4-traders.com - December 20 at 3:36 PM
finance.yahoo.com logo8:12 am Threshold Pharma enters into a collaboration with the National Cancer Institute to study TH-3424 (NASDAQ:THLD)
finance.yahoo.com - December 20 at 3:35 PM
finance.yahoo.com logoThreshold Pharmaceuticals and National Cancer Institute to Collaborate on Drug Candidate TH-3424 (NASDAQ:THLD)
finance.yahoo.com - December 19 at 9:55 AM
insidermonkey.com logoIs Threshold Pharmaceuticals, Inc. (THLD) A Good Stock To Buy? (NASDAQ:THLD)
www.insidermonkey.com - December 12 at 8:19 PM
News IconNarrowing in on the Numbers for Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - OIB News (NASDAQ:THLD)
oibnews.com - December 12 at 3:19 PM
istreetwire.com logoStocks in the Spotlight: T-Mobile US, Inc. (TMUS), Threshold Pharmaceuticals, Inc. (THLD), NiSource Inc. (NI) - iStreetWire (NASDAQ:THLD)
istreetwire.com - December 12 at 8:43 AM
News IconEV Check on Shares of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Wall Street Beacon (NASDAQ:THLD)
wsbeacon.com - December 9 at 8:06 PM
prnewswire.com logoTechnical Reports on Biotech Equities -- Aurinia Pharma, Threshold Pharma, Regeneron Pharma, and INSYS ... - PR Newswire (press release) (NASDAQ:THLD)
www.prnewswire.com - December 9 at 9:45 AM
News IconMarket Scope: Taking a Look at Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Liberty News (NASDAQ:THLD)
libertynewsrecord.com - December 9 at 9:45 AM

Social

What is Threshold Pharmaceuticals' stock symbol?

Threshold Pharmaceuticals trades on the NASDAQ under the ticker symbol "THLD."

Where is Threshold Pharmaceuticals' stock going? Where will Threshold Pharmaceuticals' stock price be in 2017?

1 brokers have issued 12-month target prices for Threshold Pharmaceuticals' stock. Their predictions range from $0.52 to $0.52. On average, they anticipate Threshold Pharmaceuticals' stock price to reach $0.52 in the next twelve months.

When will Threshold Pharmaceuticals announce their earnings?

Threshold Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Wednesday, March, 8th 2017.

Who owns Threshold Pharmaceuticals stock?

Threshold Pharmaceuticals' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Deerfield Management Co. (3.08%), Renaissance Technologies LLC (0.87%) and FMR LLC (0.56%).

Who sold Threshold Pharmaceuticals stock? Who is selling Threshold Pharmaceuticals stock?

Threshold Pharmaceuticals' stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.

Who bought Threshold Pharmaceuticals stock? Who is buying Threshold Pharmaceuticals stock?

Threshold Pharmaceuticals' stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC.

How do I buy Threshold Pharmaceuticals stock?

Shares of Threshold Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Threshold Pharmaceuticals stock cost?

One share of Threshold Pharmaceuticals stock can currently be purchased for approximately $0.60.

Threshold Pharmaceuticals (NASDAQ:THLD) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Threshold Pharmaceuticals (NASDAQ:THLD)

Earnings History Chart

Earnings by Quarter for Threshold Pharmaceuticals (NASDAQ:THLD)

Dividend History Chart

Dividend Payments by Quarter for Threshold Pharmaceuticals (NASDAQ:THLD)

Last Updated on 2/27/2017 by MarketBeat.com Staff